Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (11): 1807-1808.doi: 10.4103/1673-5374.219040.

Previous Articles     Next Articles

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury

Alexander G. Rabchevsky1, 2, Samir P. Patel1, 2, Patrick G. Sullivan1, 3, 4   

  1. 1 Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA;
    2 Departments of Physiology, University of Kentucky, Lexington, KY, USA ;
    3 Departments of Neuroscience, University of Kentucky, Lexington, KY, USA;
    4 Veterans Administration Medical Center, University of Kentucky, Lexington, KY, USA
  • Received:2017-10-12 Online:2017-11-15 Published:2017-11-15
  • Contact: Alexander G. Rabchevsky, Ph.D.,agrab@uky.edu.
  • Supported by:

    This work was funded by NIH R21NS096670 (AGR), Craig H.Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

PDF

290